Effect of Reverse Vessel Remodeling on Regression of Coronary Atherosclerosis in Patients Treated With Aggressive Lipid- and Blood Pressure-Lowering Therapy - Insight From MILLION Study

Circulation Journal : Official Journal of the Japanese Circulation Society
Tadatsugu GamouMILLION Study Group

Abstract

The MILLION study, a prospective randomized multicenter study, revealed that lipid and blood pressure (BP)-lowering therapy resulted in regression of coronary plaque as determined by intravascular ultrasound (IVUS). In the present study we performed additional analysis to investigate the associated factors with regression of coronary plaque.Methods and Results:We investigated serial 3D IVUS images from 68 patients in the MILLION study. Standard IVUS parameters were assessed at both baseline and follow-up (18-24 months). Volumetric data were standardized by length as normalized volume. In patients with plaque regression (n=52), plaque volumenormalizedsignificantly decreased from 64.8 to 55.8 mm3(P<0.0001) and vessel volumenormalizedsignificantly decreased from 135.0 to 127.5 mm3(P=0.0008). There was no difference in lumen volumenormalizedfrom 70.1 to 71.8 mm3(P=0.27). There were no correlations between % changes in vessel volume and cholesterol or BP. On the other hand, negative correlations between % change in vessel volume and vessel volumenormalizedat baseline (r=-0.352, P=0.009) or plaque volumenormalizedat baseline (r=-0.336, P=0.01) were observed. The current data demonstrated that in patients with plaque regression treate...Continue Reading

References

May 28, 1987·The New England Journal of Medicine·S GlagovG J Kolettis
Mar 15, 1993·The American Journal of Cardiology·J B HermillerC J Davidson
Feb 28, 2002·Circulation·Amanda M VarnavaMichael J Davies
Nov 13, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN CAMELOT Investigators
Mar 15, 2006·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN ASTEROID Investigators
Feb 8, 2007·JAMA : the Journal of the American Medical Association·Stephen J NichollsSteven E Nissen
Mar 28, 2007·The New England Journal of Medicine·Steven E NissenUNKNOWN ILLUSTRATE Investigators
Oct 30, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroaki TakashimaTakayuki Ito
Apr 2, 2008·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN PERISCOPE Investigators
Mar 28, 2009·Journal of the American College of Cardiology·Adnan K ChhatriwallaSteven E Nissen
Aug 6, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Takahide KohroUNKNOWN JCADII Investigators
Mar 28, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Katsumi MiyauchiUNKNOWN JAPAN-ACS Investigators
Nov 16, 2016·JAMA : the Journal of the American Medical Association·Stephen J NichollsSteven E Nissen

❮ Previous
Next ❯

Citations

Aug 11, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Noboru FujinoUNKNOWN all the members of the Japanese Circulation Society in Hokuriku District
Sep 27, 2018·Journal of Atherosclerosis and Thrombosis·Kenji SakataUNKNOWN behalf of the MILLION Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.